Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience-Reference-Cited by-同舟云学术

Treatment of chronic hepatitis C with peginterferon alfa-2b, plus ribavirin in end stage renal disease patients treated by hemodialysis: single Saudi center experience

Published:2013-09-24 Issue:10 Volume:35 Page:1305-1309
ISSN:0886-022X
Container-title:Renal Failure
language:en
Short-container-title:Renal Failure

Author:

Alsaran Khalid,Sabry Alaa,Molhem Azeb

Publisher

Informa UK Limited

Subject

Nephrology,Critical Care and Intensive Care Medicine,General Medicine

Link

http://www.tandfonline.com/doi/pdf/10.3109/0886022X.2013.826136

Reference22 articles.

1. Epidemiology and Treatment of Hepatitis C Genotypes 5 and 6

2. Quality control measures for lowering the seroconversion rate of hemodialysis patients with hepatitis B or C virus

3. Hepatitis C in dialysis units: The Saudi experience

4. Hepatitis C Virus: Biological and Clinical Consequences of Genetic Heterogeneity

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pegylated interferon alpha 2a for the treatment of hepatitis C virus infection;Expert Opinion on Drug Metabolism & Toxicology;2018-01-02

2. Safety and Efficacy of Pegylated Interferon Alpha-2b Monotherapy in Hepatitis C Virus-Infected Children with End-Stage Renal Disease on Hemodialysis;Journal of Interferon & Cytokine Research;2016-12

3. Antiviral therapy (pegylated interferon and ribavirin) of hepatitis C in dialysis patients: meta-analysis of clinical studies;Journal of Viral Hepatitis;2014-07-16

4. Hepatitis C virus infection in end-stage renal disease and kidney transplantation;Transplant International;2014-06-19